Latest Transformation News

Butn Limited has reported record revenue growth and its first positive operating cash flow for FY25, alongside securing a substantial $100 million funding facility to fuel future expansion.

Vertex Minerals has commenced high-grade underground gold production at its Reward Mine, processing first ore through a new gravity-only plant and aiming to replace low-grade surface stockpiles with richer underground feed.

Neuren Pharmaceuticals has initiated the first US investigational site for its pivotal Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, marking a significant milestone in addressing this rare neurodevelopmental disorder.

EVT Limited reported solid full-year FY25 results with revenue and profit growth, driven by record hotel performance and a recovering entertainment division. The group signals confidence with a strong dividend and optimistic FY26 outlook.

Genetic Signatures reported a 63% revenue increase to $15.9 million in FY25, alongside a 28% reduction in underlying losses and a strategic shift in its automated diagnostics platform development.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.

Rubicon Water reported a record FY25 revenue of A$69.1 million, driven by strong growth in the US and Rest of World markets, while reducing its net loss and building a robust project pipeline for FY26.

Rubicon Water’s FY25 results reveal strong global revenue growth led by the US and EMEA, alongside a narrowing EBITDA loss despite operational headwinds and strategic restructuring in China.

Michael Hill International reported a steady FY25 with revenue holding firm at $643.7 million and a return to profitability despite ongoing retail challenges. The year saw strategic store closures, digital sales growth, and leadership changes, setting the stage for a reset under new CEO Jonathan Waecker.

LTR Pharma’s SPONTAN nasal spray has achieved unanimous patient satisfaction in treating erectile dysfunction after prostate surgery, signaling a promising shift in therapy preferences.

Tolu Minerals has completed a new access road to its Tolukuma Gold Mine, enabling vehicle access from Port Moresby and slashing operational costs by over 75%. This infrastructure milestone also opens vast new exploration opportunities and benefits local communities.

Sayona Mining has significantly increased the Mineral Resource and Ore Reserves at its Moblan Lithium Project in Quebec, reinforcing the project's long-term viability amid rising lithium demand.